These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11353448)

  • 21. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
    Miura I; Takeuchi S; Katsumi A; Mori A; Kanno K; Yang Q; Mashiko H; Numata Y; Niwa S
    J Clin Psychopharmacol; 2012 Feb; 32(1):106-9. PubMed ID: 22198450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic predisposition in alcoholism: association of the D2 dopamine receptor TaqI B1 RFLP with severe alcoholics.
    Blum K; Noble EP; Sheridan PJ; Montgomery A; Ritchie T; Ozkaragoz T; Fitch RJ; Wood R; Finley O; Sadlack F
    Alcohol; 1993; 10(1):59-67. PubMed ID: 8095394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia.
    Nagai G; Mihara K; Nakamura A; Suzuki T; Nemoto K; Kagawa S; Ohta I; Arakaki H; Kondo T
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):518-24. PubMed ID: 23066770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does DRD2 polymorphism influence the clinical characteristics of prolactinoma?
    Ilhan M; Kahraman OT; Turan S; Turgut S; Karaman O; Zeybek U; Shukurov S; Yaylim I; Tasan E
    Ann Endocrinol (Paris); 2015 Oct; 76(5):614-9. PubMed ID: 26514951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine.
    Aklillu E; Kalow W; Endrenyi L; Harper P; Miura J; Ozdemir V
    Pharmacogenet Genomics; 2007 Nov; 17(11):989-93. PubMed ID: 18075468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.
    Roke Y; van Harten PN; Franke B; Galesloot TE; Boot AM; Buitelaar JK
    Pharmacogenet Genomics; 2013 Sep; 23(9):487-93. PubMed ID: 23851570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report.
    Blum K; Braverman ER; Wood RC; Gill J; Li C; Chen TJ; Taub M; Montgomery AR; Sheridan PJ; Cull JG
    Pharmacogenetics; 1996 Aug; 6(4):297-305. PubMed ID: 8873216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population.
    Kaneshima M; Higa T; Nakamoto H; Nagamine M
    Psychiatry Clin Neurosci; 1997 Dec; 51(6):379-81. PubMed ID: 9472122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DRD2 Taq1A polymorphism modulates prolactin secretion induced by atypical antipsychotics in healthy volunteers.
    López-Rodríguez R; Román M; Novalbos J; Pelegrina ML; Ochoa D; Abad-Santos F
    J Clin Psychopharmacol; 2011 Oct; 31(5):555-62. PubMed ID: 21869700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine D2 receptor genotype is associated with increased mortality at a 10-year follow-up of alcohol-dependent individuals.
    Berggren U; Fahlke C; Berglund KJ; Wadell K; Zetterberg H; Blennow K; Thelle D; Balldin J
    Alcohol Alcohol; 2010; 45(1):1-5. PubMed ID: 19654188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association of allele polymorphism of dopamine d2 receptors with schizophrenic and affective disorders].
    Golimbet VE; Aksenova MG; Abramova LI; Kaleda VG; Orlova VA; Braga EA; Nosikov VV; Trubnikov VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(12):32-5. PubMed ID: 9866157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome.
    Mihara K; Kondo T; Suzuki A; Yasui-Furukori N; Ono S; Sano A; Koshiro K; Otani K; Kaneko S
    Am J Med Genet B Neuropsychiatr Genet; 2003 Feb; 117B(1):57-60. PubMed ID: 12555236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linkage and association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population.
    Behravan J; Hemayatkar M; Toufani H; Abdollahian E
    Arch Iran Med; 2008 May; 11(3):252-6. PubMed ID: 18426314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas.
    Filopanti M; Barbieri AM; Angioni AR; Colao A; Gasco V; Grottoli S; Peri A; Baglioni S; Fustini MF; Pigliaru F; Monte PD; Borretta G; Ambrosi B; Jaffrain-Rea ML; Gasperi M; Brogioni S; Cannavò S; Mantovani G; Beck-Peccoz P; Lania A; Spada A
    Pharmacogenomics J; 2008 Oct; 8(5):357-63. PubMed ID: 18332900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The TaqI A DRD2 polymorphism in type II alcohol dependence: a marker of age at onset or of a familial disease?
    Pinto E; Reggers J; Gorwood P; Boni C; Scantamburlo G; Pitchot W; Ansseau M
    Alcohol; 2009 Jun; 43(4):271-5. PubMed ID: 19376678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcoholics with the dopamine receptor DRD2 A1 allele have lower platelet monoamine oxidase-B activity than those with the A2 allele: a preliminary study.
    Eriksson M; Berggren U; Blennow K; Fahlke C; Månsson JE; Balldin J
    Alcohol Alcohol; 2000; 35(5):493-8. PubMed ID: 11022024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DRD2 haplotypes containing the TaqI A1 allele: implications for alcoholism research.
    Kidd KK; Pakstis AJ; Castiglione CM; Kidd JR; Speed WC; Goldman D; Knowler WC; Lu RB; Bonne-Tamir B
    Alcohol Clin Exp Res; 1996 Jun; 20(4):697-705. PubMed ID: 8800387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dopamine D2 receptor gene TaqI A1 polymorphism and alcoholism in a Mexican population.
    Cruz C; Camarena B; Mejía JM; Páez F; Eroza V; Ramón De La Fuente J; Kershenobich D; Nicolini H
    Arch Med Res; 1995; 26(4):421-6. PubMed ID: 8555738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.
    Eisenstein SA; Bogdan R; Love-Gregory L; Corral-Frías NS; Koller JM; Black KJ; Moerlein SM; Perlmutter JS; Barch DM; Hershey T
    Synapse; 2016 Oct; 70(10):418-31. PubMed ID: 27241797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of the Taq1 dopamine D2 receptor gene and percent body fat in obese and screened control subjects: a preliminary report.
    Chen AL; Blum K; Chen TJ; Giordano J; Downs BW; Han D; Barh D; Braverman ER
    Food Funct; 2012 Jan; 3(1):40-8. PubMed ID: 22051885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.